Medicare GLP-1 Bridge Program: What Alabama Pharmacy Technicians Need to Know (2026)

Last reviewed July 2026 by Tyler Dalton, PharmD.

Starting July 1, 2026, the Medicare GLP-1 Bridge Program gives eligible Medicare Part D and MA-PD beneficiaries access to Wegovy, Zepbound, and Foundayo for weight management at about $50 per month — far below typical cash prices that often exceed $1,000/month without coverage. The demonstration runs through December 31, 2027.

For Alabama pharmacy technicians, Bridge is one of the largest billing changes to hit retail counters in years. GLP-1 volume is already surging in Birmingham, Huntsville, Mobile, Montgomery, and independent stores statewide. Bridge adds a second Medicare billing pathway outside your normal Part D switch — and techs who master it early will prevent costly reversals, RTS loops, and frustrated patients at pickup.

---

What is the Medicare GLP-1 Bridge Program?

The Bridge is a temporary CMS Section 402 demonstration — not a standard Part D benefit — that expands access to FDA-approved GLP-1 medications for weight management while CMS collects utilization data ahead of the delayed BALANCE Model.

According to CMS, Bridge operates outside the Part D payment flow. Part D plans do not carry financial risk, do not need to opt in, and do not adjudicate Bridge claims. Instead, CMS uses a central processor (Humana via LI NET infrastructure) for prior authorization, claims adjudication, and pharmacy payment.

Key facts to memorize:

• Launch: July 1, 2026 · End: December 31, 2027
• Patient copay: $50/month (does not count toward Part D TrOOP or deductible)
• No LIS subsidy on Bridge copays — $50 is flat for all eligible fills
• Supply limit: 1-month fills only on covered products
• Pharmacies: No opt-in required — but you must use Bridge billing credentials

---

Official CMS & Medicare resources

Bookmark these before go-live:

• CMS Medicare GLP-1 Bridge hub — FAQs, PA forms, beneficiary info
• CMS Bridge payer sheet (PDF) — BIN, PCN, NCPDP fields, help desk
• Bridge Expectations & FAQs for Part D sponsors (PDF) — clinical exclusion rules
• CMS press release — $50 monthly GLP-1 access
• CMS Innovation Center — Bridge model page
• HPMS memo — Bridge Expectations for Part D sponsors — when to redirect patients back to Part D
• Beneficiary info: Medicare.gov/glp1bridge · 1-800-MEDICARE (1-800-633-4227)
• CMS Bridge questions: GLP1Demo@cms.hhs.gov · Pharmacy help desk: 844-673-0910

---

Who qualifies for Bridge?

Eligible patients must meet CMS criteria, including:

• Enrollment in Medicare Part D (standalone PDP), MA-PD, SNP, EGWP, or LI NET
• BMI ≥ 30, or BMI ≥ 27 with a weight-related comorbidity
• Prescription for weight management with supporting ICD-10 codes
• No Part D-coverable indication on the same Rx (e.g., Zepbound for OSA or Wegovy for CV risk stays on Part D)
• No prior 2026 Part D GLP-1 fill for some eligibility tiers (confirm current CMS tier rules)
• A covered Bridge product dispensed as a 1-month supply

Technician tip: Never assume Bridge eligibility from a Medicare card. Run the Bridge-specific workflow — the Part D BIN that pays for metformin will reject a misrouted Wegovy claim.

---

Covered drugs vs. what stays on Part D

Product	Bridge eligible?	Notes
Wegovy (pen or tablet)	Yes	Weight-management indication
Zepbound KwikPen	Yes	Multi-dose pen only — not single-dose vials/pens
Foundayo (orforglipron)	Yes	Per CMS listing
Ozempic, Mounjaro, Trulicity	No (diabetes)	Bill through standard Part D
Wegovy/Zepbound for CV or OSA indications	No	Part D coverable — better for patient OOP cap

If the SIG and diagnosis support diabetes management, do not force Bridge. Mismatching product to processor is a top rejection cause.

---

Pharmacy billing: BIN, PCN, and reimbursement

This is the section every Alabama pharmacy tech needs before July 1.

Bridge claim credentials (CMS payer sheet)

Per the official CMS GLP-1 Bridge payer sheet:

Field	Value
Payer / Plan name	GLP1Bridge
BIN	028918
PCN	MEDDGLP1BR
Processor	SS&C Health — route through RelayHealth
NCPDP standard	D.0
Effective date	July 1, 2026
Help desk	844-673-0910
Certification testing	Not required

How reimbursement works

CMS reimburses pharmacies at wholesale acquisition cost (WAC), minus the $50 patient copay, plus a dispensing fee, plus applicable sales tax. Pharmacies collect the $50 copay at pickup; the central processor pays the balance.

This is not your Part D plan's negotiated rate. Do not bill Bridge to the patient's Aetna, Humana, SilverScript, or Wellcare Part D BIN — even if that plan is their primary drug coverage.

Step-by-step billing workflow for technicians

1. Verify patient has Part D or MA-PD (Bridge requires Part D enrollment, not Medigap-only)
2. Confirm Bridge eligibility — BMI, indication, covered product, 1-month supply
3. Check PA status — prescriber submits PA to central processor (not Part D plan)
4. Enter claim using BIN 028918 / PCN MEDDGLP1BR — not the plan BIN
5. Collect $50 copay from patient at pickup
6. Dispense 1-month supply; document cold-chain for pens
7. If rejected, read rejection code — wrong BIN and missing PA are the top two fixes

Prior authorization and prescriber workflow

Bridge PA goes to the CMS central processor (administered by Humana via LI NET infrastructure), not the Part D sponsor. Key points for pharmacy teams:

• Prescribers submit PA and the prescription to the central processor — patients do not self-enroll through a public application portal
• Pharmacies may need to transmit a test claim to establish a record before PA approval in some workflows
• Prescribers may use CoverMyMeds or fax per CMS guidance — download the current PA form from the CMS Bridge hub (do not submit PA before July 1, 2026)
• If a patient was already approved for Zepbound for obstructive sleep apnea or Wegovy for cardiovascular risk reduction, CMS expects those fills through Part D, not Bridge — see the Bridge Expectations & FAQs PDF

NCPDP D.0 claim entry checklist

Before you hit Submit, techs should verify:

1. NCPDP version D.0 — Bridge does not accept legacy D.0 rejections from outdated switch configs
2. BIN 028918 / PCN MEDDGLP1BR — double-check against the payer sheet PDF, not the patient's SilverScript or Wellcare card
3. Days supply ≤ 28–30 days on weekly GLP-1 pens — Bridge rejects multi-month fills
4. Quantity matches SIG — four Wegovy pens for Q weekly = 28-day supply, not 84
5. Patient copay $50.00 collected at pickup — Bridge copay does not flow through LIS or Extra Help subsidies
6. Medicare Beneficiary Identifier (MBI) on file — Bridge uses Medicare ID, not the old HICN in most workflows

If your software has a saved Third Party plan for Bridge, build it now using CMS credentials so techs cannot accidentally select the wrong Part D BIN during busy shifts.

Eligibility tiers techs should know (patient intake)

CMS published tiered BMI rules for Bridge — confirm the latest tier chart on the CMS hub before counseling patients:

• Tier 1: BMI ≥ 35 (weight management indication)
• Tier 2: BMI ≥ 30 with a qualifying comorbidity (hypertension, heart failure, CKD, etc.)
• Tier 3: BMI ≥ 27 with specific conditions such as prediabetes, prior MI, stroke, or PAD

Technicians do not diagnose eligibility, but you can flag when a patient mentions diabetes-only Ozempic while the prescriber selected Bridge — that mismatch causes reversals.

After Bridge ends: BALANCE Model

Bridge runs July 1, 2026 through December 31, 2027 as a transition to CMS's BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model, which shifts GLP-1 weight-management coverage into longer-term Part D policy. Pharmacies should expect new billing rules in 2027 — bookmark the CMS Innovation Center Bridge page for model updates.

---

Days supply for every GLP-1 Bridge medication

Bridge limits 1-month supplies, so every covered product bills out at a 28-day supply. Here is the math for each one.

Medication	Package and quantity	Typical SIG	Days supply math	Days supply
Wegovy single-dose pen (semaglutide)	4 pens per carton, quantity 4	Inject 1 pen weekly	4 pens ÷ 1 per week = 4 weeks × 7	28
Wegovy oral tablet (semaglutide)	28 tablets, quantity 28	Take 1 tablet daily	28 ÷ 1 per day	28
Zepbound KwikPen (tirzepatide)	4 weekly doses per carton	Inject 1 dose weekly	4 weekly doses × 7	28
Zepbound single-dose pen or vial (tirzepatide)	4 pens or vials, quantity 4	Inject 1 dose weekly	4 doses ÷ 1 per week = 4 weeks × 7	28
Foundayo oral tablet (orforglipron)	28 tablets, quantity 28	Take 1 tablet daily	28 ÷ 1 per day	28

Rules of thumb:

• Weekly injectables: days supply = weekly doses in the dispensed package × 7
• Daily orals: days supply = tablet count ÷ tablets per day
• RTS rejections often appear around days 21–25
• A partial fill bills the days supply actually dispensed, which resets the refill window

Run the math before submitting. Use our free Wegovy day supply calculator, the Mounjaro/Zepbound guide, or the full days supply calculator. For RTS and PA logic, see Insurance Math & Rejection Logic.

---

Two separate programs, two separate guides

Patients ask about the Medicare GLP-1 Bridge Program and TrumpRx at the same counter, but they are not the same thing. Bridge runs a real claim for eligible Medicare members at about $50 per month. TrumpRx is a federal cash-price website with no claim and no credit toward Part D costs.

Each one now has its own full guide:

• Medicare GLP-1 Bridge Program: billing and days supply for every covered medication
• What is TrumpRx? A pharmacy technician guide to federal cash pricing

---

Alabama-specific notes

Alabama Medicaid GLP-1 obesity coverage uses separate PA and BMI rules — not Bridge. Dual-eligible and newly Medicare-aged patients need active coverage verified every fill.

Under ALBOP Rule 680-X-2-.14, technicians work under direct pharmacist supervision. Techs own data entry, insurance routing, and inventory; pharmacists own counseling and clinical decisions.

Independent Alabama pharmacies: GLP-1 pens tie up high WAC dollars. Do not overstock until your PSAO confirms Bridge payment turnaround.

---

Medicare beneficiary perspective — Dalton Insurance

This article focuses on pharmacy technician workflow. For the patient and Medicare beneficiary side — how Bridge interacts with Part D formularies, MA-PD networks, and out-of-pocket costs — see Tyler Dalton, PharmD at Dalton Insurance, the same family of practices behind Alabama Pharm Tech training.

Dalton Insurance has not yet published a standalone GLP-1 Bridge article on dalton-insurance.com as of July 2026. These are the closest published guides for beneficiaries asking about Medicare drug coverage and how Bridge fits in:

• Guide to Medicare Part D: Prescription Drug Plans — formularies, tiers, pharmacy networks, and how standalone Part D differs from MA-PD (critical context because Bridge sits outside both)
• Prescription Coverage — Medicare Part D overview — deductibles, initial coverage, and specialty-drug tiers that explain why Bridge exists for weight-loss GLP-1s
• Free Medicare guidance & plan comparisons — schedule a call with Tyler Dalton's team for Alabama Medicare Part D help
• Phone: (334) 489-3624

If a patient asks whether Bridge or their Part D plan is cheaper for Wegovy, send them to Dalton Insurance for beneficiary counseling — techs should stay in billing and data-entry lane under pharmacist supervision.

---

Common rejections and tech fixes

Rejection	Likely cause	Tech action
Patient not eligible	Not in qualifying Part D/MA-PD	Verify Bridge eligibility
Product not covered	Ozempic billed as Bridge	Confirm weight-loss vs. diabetes indication
Diagnosis mismatch	Missing weight ICD-10	Fax prescriber
RTS / early refill	28-day fill too early	Recalculate days supply
Wrong processor	Part D BIN used	Rebill 028918 / MEDDGLP1BR
PA required	No central-processor approval	Hold fill; contact prescriber

When stuck, call 844-673-0910 (Bridge help desk) and document the call.

---

FAQ

When does Bridge start?

July 1, 2026, through December 31, 2027.

What BIN and PCN do pharmacies use?

BIN 028918 and PCN MEDDGLP1BR per the CMS payer sheet.

Does the $50 copay count toward Part D out-of-pocket max?

No. Bridge is outside Part D — the $50 does not apply to TrOOP, deductible, or LIS subsidies.

Does Bridge cover Ozempic?

Not for diabetes-only indications. Ozempic stays on standard Part D. Bridge covers Wegovy, Zepbound KwikPen, and Foundayo for weight management.

Can pharmacy technicians submit Bridge claims?

Yes, under pharmacist supervision per store policy and Alabama law.

---

Scroll down for cost comparison charts, implementation timeline, workflow checklists, CMS document links, and free GLP-1 practice tools.